Moyamoya angiopathy in Europe

Abstract

This chapter deals with moyamoya angiopathy (MMA) [1, 2], [moyamoya disease (MMD), moyamoya syndrome (MMS), and unilateral MM pathology] in Europe. Although this terminology MMA might give rise to some objections, it is considered to be acceptable from the clinical and practical points of view [2, 3], as the senior author (Y.Y.) has experience of a considerable number of patients with this pathology in Japan and in Europe (Zürich). As knowledge of recent investigation on its pathophysiology and etiology has been outlined elsewhere [2], we focus our attention here on our clinical experience in Zürich and attempt to clarify some differences between MMA in Europe and in Japan. © 2010 Springer-Verlag Tokyo.